These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26747068)

  • 41. Clinical evaluation of the need for carbapenems to treat community-acquired and healthcare-associated pneumonia.
    Kamata K; Suzuki H; Kanemoto K; Tokuda Y; Shiotani S; Hirose Y; Suzuki M; Ishikawa H
    J Infect Chemother; 2015 Aug; 21(8):596-603. PubMed ID: 26070781
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Severe hospital acquired pneumonia and septicemia due TO methicillin resistant Staphylococcus lugdunensis in a newborn in Northwestern Ethiopia.
    Tibebu M
    Ethiop Med J; 2014 Apr; 52(2):99-101. PubMed ID: 25588292
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Outcomes associated with bacteremia in the setting of methicillin-resistant Staphylococcus aureus pneumonia: a retrospective cohort study.
    Shorr AF; Zilberberg MD; Micek ST; Kollef MH
    Crit Care; 2015 Sep; 19(1):312. PubMed ID: 26335247
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Risk factors associated with potentially antibiotic-resistant pathogens in community-acquired pneumonia.
    Prina E; Ranzani OT; Polverino E; Cillóniz C; Ferrer M; Fernandez L; Puig de la Bellacasa J; Menéndez R; Mensa J; Torres A
    Ann Am Thorac Soc; 2015 Feb; 12(2):153-60. PubMed ID: 25521229
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence of macrolide, lincosamide, and streptogramin resistance among staphylococci in a tertiary care hospital in Athens, Greece.
    Vallianou N; Evangelopoulos A; Hadjisoteriou M; Avlami A; Petrikkos G
    J Chemother; 2015; 27(6):319-23. PubMed ID: 25112954
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Variations in sensitivity to antibiotics of staphylococci strains isolated from alimentary workers between 1985-1987.
    Gelosa L
    J Chemother; 1989 Jul; 1(4 Suppl):275-6. PubMed ID: 16312399
    [No Abstract]   [Full Text] [Related]  

  • 47. Ceftolozane/tazobactam activity tested against Gram-negative bacterial isolates from hospitalised patients with pneumonia in US and European medical centres (2012).
    Farrell DJ; Sader HS; Flamm RK; Jones RN
    Int J Antimicrob Agents; 2014 Jun; 43(6):533-9. PubMed ID: 24856078
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Linezolid in methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a randomized, controlled study.
    Wunderink RG; Niederman MS; Kollef MH; Shorr AF; Kunkel MJ; Baruch A; McGee WT; Reisman A; Chastre J
    Clin Infect Dis; 2012 Mar; 54(5):621-9. PubMed ID: 22247123
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment options for nosocomial pneumonia due to MRSA.
    Niederman MS
    J Infect; 2009 Sep; 59 Suppl 1():S25-31. PubMed ID: 19766886
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative studies on the composition and antibiotic-resistance of pathogenic bacteria between children with community-acquired and hospital-acquired pneumonia].
    Wang Z; Ji W; Guo HB; Tao YZ; Ding YF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Mar; 45(3):211-6. PubMed ID: 21624231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Staphylococcus aureus pneumonia: a "superbug" infection in community and hospital settings.
    Kollef MH; Micek ST
    Chest; 2005 Sep; 128(3):1093-7. PubMed ID: 16162690
    [No Abstract]   [Full Text] [Related]  

  • 52. Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting.
    Nicoletti G; Schito G; Fadda G; Boros S; Nicolosi D; Marchese A; Spanu T; Pantosti A; Monaco M; Rezza G; Cassone A; Garaci E;
    J Chemother; 2006 Dec; 18(6):589-602. PubMed ID: 17267336
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Methicillin resistance is not a predictor of severity in community-acquired Staphylococcus aureus necrotizing pneumonia--results of a prospective observational study.
    Sicot N; Khanafer N; Meyssonnier V; Dumitrescu O; Tristan A; Bes M; Lina G; Vandenesch F; Vanhems P; Etienne J; Gillet Y
    Clin Microbiol Infect; 2013 Mar; 19(3):E142-8. PubMed ID: 23237492
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults.
    Hashemi SH; Soozanchi G; Jamal-Omidi S; Yousefi-Mashouf R; Mamani M; Seif-Rabiei MA
    Trop Doct; 2010 Apr; 40(2):89-91. PubMed ID: 20305102
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pharmacodynamic simulation to assess tigecycline efficacy for hospital-acquired pneumonia compared with other common intravenous antibiotics.
    Kuti JL; Dowzicky M; Nicolau DP
    J Chemother; 2008 Feb; 20(1):69-76. PubMed ID: 18343747
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy.
    Riou M; Carbonnelle S; Avrain L; Mesaros N; Pirnay JP; Bilocq F; De Vos D; Simon A; Piérard D; Jacobs F; Dediste A; Tulkens PM; Van Bambeke F; Glupczynski Y
    Int J Antimicrob Agents; 2010 Dec; 36(6):513-22. PubMed ID: 20926262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of severe pneumonia--community-acquired and "early onset" nosocomial].
    Höffken G; Halank M; Gillissen A
    Med Klin (Munich); 2004 Jul; 99(7):362-71. PubMed ID: 15322715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro activities of 18 antimicrobial agents against Staphylococcus aureus isolates from the Institut Pasteur of Madagascar.
    Randrianirina F; Soares JL; Ratsima E; Carod JF; Combe P; Grosjean P; Richard V; Talarmin A
    Ann Clin Microbiol Antimicrob; 2007 May; 6():5. PubMed ID: 17521424
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The comparative development of elevated resistance to macrolides in community-acquired pneumonia caused by Streptococcus pneumoniae.
    Yayan J
    Drug Des Devel Ther; 2014; 8():1733-43. PubMed ID: 25336917
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibiotic treatment of staphylococcal pneumonia in adults.
    Bagg R
    J Antimicrob Chemother; 1978 Jul; 4(4):297-9. PubMed ID: 308503
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.